PBLA

Panbela Therapeutics (PBLA)

Panbela Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PBLA

1 2 3 4 5 6 7 8 9 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/29	20 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/05/16	05 : 10	GlobeNewswire Inc.	Panbela Provides Business Update and Reports Q1 2024 Financial Results	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/05/06	21 : 00	GlobeNewswire Inc.	Panbela Announces Issuance of New Patent in the US and Canada; Patent is for Claims of a Fixed Dose Combination of Eflornithine and Sulindac	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/05/02	05 : 15	GlobeNewswire Inc.	Panbela to Host First Quarter 2024 Earnings Conference Call on May 15, 2024	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/04/30	21 : 00	GlobeNewswire Inc.	Acceptance of Eflornithine (DFMO) Abstract for Oral Presentation at Digestive Disease Week	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/04/27	05 : 39	Edgar (US Regulatory)	Form PRER14A - Preliminary Proxy Soliciting materials	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/04/26	05 : 36	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/04/26	05 : 35	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/04/25	22 : 09	Edgar (US Regulatory)	Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/04/22	21 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/04/22	21 : 00	GlobeNewswire Inc.	Panbela Therapeutics Announces Interim Data Analysis for ASPIRE Trial Pushed to Q1 2025	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/04/19	05 : 31	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/04/18	21 : 00	GlobeNewswire Inc.	Panbela Announces Poster Presentation at American Association for Cancer Research:	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/04/17	21 : 36	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/04/17	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/04/17	06 : 29	GlobeNewswire Inc.	Panbela Announces Transfer to OTCQB Market	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/04/05	05 : 17	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/04/03	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/03/30	06 : 24	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/03/30	06 : 08	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/03/27	05 : 15	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/03/27	05 : 12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/03/27	05 : 10	GlobeNewswire Inc.	Panbela Provides Business Update and Reports Q4 and FY 2024 Financial Results	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/03/26	20 : 21	IH Market News	U.S. Index Futures on the Rise, Oil Prices Show Stability	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/03/26	05 : 15	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/03/13	05 : 15	GlobeNewswire Inc.	Panbela to Host Fourth Quarter and Year End 2023 Earnings Conference Call on March 26, 2024	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/03/07	20 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/02/15	22 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/02/15	22 : 00	GlobeNewswire Inc.	Panbela Regains Compliance with Nasdaq Listing Standards for Bid Price and Publicly Held Shares Requirements	NASDAQ:PBLA	Panbela Therapeutics Inc
2024/02/14	10 : 10	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:PBLA	Panbela Therapeutics Inc